Logo Prima Biomed

Company Calendar

  • October 31th , 2017

    World Immunotherapy Congress, Basel, Switzerland

    Frédéric Triebel
    is speaking about TACTI-mel, two ACTive immunotherapies in melanoma: combination of an APC activator (IMP321 or LAG-3Ig) with Pembrolizumab at 5:50 PM.

     

    http://www.terrapinn.com/conference/world-immunotherapy-congress

  • November 08-12, 2017

    SITC, Society for Immunotherapy of Cancer, National Harbor, MD, USA

    Frédéric Triebel is presenting a poster with results from the first two cohorts of TACITmel
    on behalf of Victoria Atkinson (principal PI, Australia)

     

    https://www.sitcancer.org

  • November 17th, 2017

    Annual General Meeting in November 2017, Sydney, Australia

  • November 16th, 2017

    ICI Europe - 3rd Annual Summit, Delivering Maximum Clinical Benefit Through Immune
    Checkpoint Modulation, Munich, Germany

    Frédéric Triebel is speaking about “Combination Strategies for LAG-3Ig (IMP321) With Either Chemotherapy or Anti-PD-1 Therapy” at 1:15 PM.


    http://immunecheckpoint-europe.com/

  • January 8-11, 2018

    36th Annual J.P. Morgan Health Care Investor Conference, San Francisco, California, USA

    http://bit.ly/2xBvH7B

  • March 19-23, 2018

    3rd Annual Immuno-Oncology Summit Europe, Hilton London Canary Wharf, London, UK

     

    http://www.immuno-oncologyeurope.com/

     

  • June 1-5, 2018

    2018 ASCO Annual Meeting, McCormick Place, Chicago, IL, USA

    https://am.asco.org/